drugset / Trial / NCT05319860

Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

NCT05319860 ↗

Phase 2 Completed 100 enrolled University of Miami
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the use of aromatherapy to reduce nausea, vomiting, and the use of anti-emetic in cancer survivors undergoing moderate to highly emetogenic chemotherapy regimens.

Timeline

Start
2022-08-01
Primary completion
2024-04-15
Completion
2024-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Aromatherapy Care Unknown — Inhaled